Adolescent Inpatient Tobacco and ENDS Intervention

Children's Mercy Hospital Kansas City

Status: Active, not recruiting

Conditions: Vaping; Smoking

Treatments: Behavioral: E-cigarette & Tobacco Use Treatment Intervention

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT05936099

5K23DA055736-02 (U.S. NIH Grant/Contract)

STUDY00002116

Details and patient eligibility

About

The purpose of this study is to develop and evaluate an evidence-based intervention to assist adolescents and young adults with current vaping to quit vaping and smoking.

Full description

Use of electronic nicotine delivery system (ENDS), which are noncombustible tobacco products (e.g., e-cigarettes), has increased dramatically among youth and is associated with numerous adverse health outcomes as well as use of alcohol and other illicit substances. National guidelines recommend counseling to address tobacco use at every adolescent clinical visit; however, many at-risk adolescents do not routinely attend primary care. Although evidence supports treatment of tobacco use during an adult hospitalization, no interventions have been developed or tested in the pediatric hospital setting. Based on promising theoretically-based evidence from the primary care and hospital settings, we will design, iteratively refine and assess implementation of a novel tobacco and ENDS use intervention for hospitalized adolescents and young adults (AYAs). We do so by conducting a randomized controlled pilot study (n=144) with 3-month follow up to evaluate preliminary efficacy as well as implementation outcomes (i.e., acceptability, feasibility, fidelity).

Enrollment: 144 estimated patients

Sex: All

Ages: 14 to 21 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Admitted to the hospital
• Screens positive for past 30 day e-cigarette use
• Parent/guardian agrees to leave the room

Exclusion criteria

• Age is less than 14 years or over 21 years
• Not comfortable speaking/reading English
• Too ill to participate
• Severe psychiatric illness
• Too developmentally delayed/cognitively impaired

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

144 participants in 2 patient groups

Control

No Intervention group

Description:

Participants will complete the baseline survey and receive an informational brochure

Intervention

Experimental group

Description:

Participants will complete the baseline survey, receive a behavioral health intervention supported by computerized decision support, and take an exit survey

Treatment:

Behavioral: E-cigarette & Tobacco Use Treatment Intervention